Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive hospital monitoring of adverse drug reactions for Yang-Xin-Shi Tablet
ChiCTR-ONC-12002633Phase 4Completed
- Sponsor
- Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences
- Start
- Sep 2014
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of yangxinshi in None, sponsored by Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences. Primary endpoint: Incidence of severe adverse drug reactions. Started Sep 2014; status: completed.
02
Drugs
yangxinshi
Beyond the preview
Go deeper on ChiCTR-ONC-12002633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-12002633.